Protara Therapeutics, Inc. Operating Cash Flow
Protara Therapeutics, Inc. (TARA) reported Operating Cash Flow of -$36.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$15.39M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$21.34M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$16.95M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$12.45M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$56.37M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$35.81M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$37.56M.
- Protara Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$26.46M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$36.73M 10-Q · filed 2026-08-11 | -$53.68M derived: sum of 3 quarters · filed 2026-08-11 | -$66.13M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$21.34M 10-Q · filed 2026-05-13 | -$38.29M derived: sum of 2 quarters · filed 2026-05-13 | -$50.74M derived: sum of 3 quarters · filed 2026-05-13 | -$62.99M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$16.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$29.40M derived: sum of 2 quarters · filed 2026-03-10 | -$41.65M derived: sum of 3 quarters · filed 2026-08-11 | -$56.37M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$12.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$24.70M derived: sum of 2 quarters · filed 2026-08-11 | -$39.41M 10-Q · filed 2025-11-10 | -$48.72M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$12.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$26.96M 10-Q · filed 2026-08-11 | -$36.27M derived: sum of 3 quarters · filed 2026-08-11 | -$44.70M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$14.71M 10-Q · filed 2026-05-13 | -$24.02M derived: sum of 2 quarters · filed 2026-05-13 | -$32.45M derived: sum of 3 quarters · filed 2026-05-13 | -$40.14M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$17.74M derived: sum of 2 quarters · filed 2026-03-10 | -$25.43M derived: sum of 3 quarters · filed 2026-03-10 | -$35.81M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | -$8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$16.12M derived: sum of 2 quarters · filed 2025-11-10 | -$26.50M 10-Q · filed 2025-11-10 | -$35.20M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$7.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$18.07M 10-Q · filed 2025-08-11 | -$26.77M derived: sum of 3 quarters · filed 2025-08-11 | -$33.33M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$10.38M 10-Q · filed 2025-05-08 | -$19.08M derived: sum of 2 quarters · filed 2025-05-08 | -$25.64M derived: sum of 3 quarters · filed 2025-05-08 | -$35.05M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$15.26M derived: sum of 2 quarters · filed 2025-03-05 | -$24.67M derived: sum of 3 quarters · filed 2025-03-05 | -$37.56M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | -$6.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$15.97M derived: sum of 2 quarters · filed 2024-11-12 | -$28.86M 10-Q · filed 2024-11-12 | -$33.88M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$9.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$22.30M 10-Q · filed 2024-08-06 | -$27.32M derived: sum of 3 quarters · filed 2024-08-06 | -$32.67M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | -$12.89M 10-Q · filed 2024-05-02 | -$17.91M derived: sum of 2 quarters · filed 2024-05-02 | -$23.26M derived: sum of 3 quarters · filed 2024-05-02 | -$28.38M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$10.37M derived: sum of 2 quarters · filed 2024-03-13 | -$15.50M derived: sum of 3 quarters · filed 2024-03-13 | -$26.46M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$5.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$10.47M derived: sum of 2 quarters · filed 2023-11-03 | -$21.43M 10-Q · filed 2023-11-03 | -$28.34M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | -$5.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$16.08M 10-Q · filed 2023-08-03 | -$22.99M derived: sum of 3 quarters · filed 2023-08-03 | -$29.19M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$10.96M 10-Q · filed 2023-05-04 | -$17.87M derived: sum of 2 quarters · filed 2023-05-04 | -$24.07M derived: sum of 3 quarters · filed 2023-05-04 | -$33.54M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$6.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$13.11M derived: sum of 2 quarters · filed 2023-03-08 | -$22.58M derived: sum of 3 quarters · filed 2023-03-08 | -$34.50M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | -$6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$15.68M derived: sum of 2 quarters · filed 2022-11-03 | -$27.59M 10-Q · filed 2022-11-03 | -$34.36M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$21.39M 10-Q · filed 2022-08-09 | -$28.16M derived: sum of 3 quarters · filed 2022-08-09 | -$31.92M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$11.92M 10-Q · filed 2022-05-05 | -$18.69M derived: sum of 2 quarters · filed 2022-05-05 | -$22.45M derived: sum of 3 quarters · filed 2022-05-05 | -$28.18M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$10.53M derived: sum of 2 quarters · filed 2022-03-09 | -$16.26M derived: sum of 3 quarters · filed 2022-03-09 | -$23.41M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$9.49M derived: sum of 2 quarters · filed 2021-11-04 | -$16.64M 10-Q · filed 2021-11-04 | -$16.64M 10-Q · filed 2020-11-12 | -$17.73M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | -$5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$12.88M 10-Q · filed 2021-08-05 | -$12.88M 10-Q · filed 2020-07-31 | -$13.97M derived: sum of 3 quarters · filed 2021-08-05 | -$15.18M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | -$7.15M 10-Q · filed 2021-05-06 | -$7.15M 10-Q · filed 2020-05-13 | -$8.23M derived: sum of 2 quarters · filed 2021-05-06 | -$9.45M derived: sum of 3 quarters · filed 2021-05-06 | -$10.75M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$2.30M derived: sum of 2 quarters · filed 2021-03-11 | -$3.60M derived: sum of 3 quarters · filed 2021-03-11 | -$5.01M 10-K · filed 2021-03-11 | -$15.65M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$2.52M derived: sum of 2 quarters · filed 2020-11-12 | -$3.92M 10-Q · filed 2020-11-12 | -$12.51M 10-Q · filed 2019-10-31 | -$8.24M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$2.71M 10-Q · filed 2020-07-31 | -$11.04M 10-Q · filed 2019-08-07 | -$7.02M derived: sum of 3 quarters · filed 2020-07-31 | -$10.14M derived: sum of 4 quarters · filed 2020-07-31 | |||
| 2019-03-31 | -$1.41M 10-Q · filed 2020-05-13 | -$5.09M 10-Q · filed 2019-05-08 | -$5.72M derived: sum of 2 quarters · filed 2020-05-13 | -$8.84M derived: sum of 3 quarters · filed 2020-05-13 | -$19.18M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$7.43M derived: sum of 2 quarters · filed 2020-03-20 | -$17.78M derived: sum of 3 quarters · filed 2020-03-20 | -$23.23M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$13.46M derived: sum of 2 quarters · filed 2019-10-31 | -$18.92M 10-Q · filed 2019-10-31 | -$24.62M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | -$10.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$15.80M 10-Q · filed 2019-08-07 | -$21.50M derived: sum of 3 quarters · filed 2019-08-07 | -$27.43M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$5.46M 10-Q · filed 2019-05-08 | -$11.15M derived: sum of 2 quarters · filed 2019-05-08 | -$17.08M derived: sum of 3 quarters · filed 2019-05-08 | -$20.36M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$11.62M derived: sum of 2 quarters · filed 2019-03-13 | -$14.91M derived: sum of 3 quarters · filed 2019-03-13 | -$22.35M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$9.21M derived: sum of 2 quarters · filed 2018-11-07 | -$16.65M 10-Q · filed 2018-11-07 | -$22.23M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$10.73M 10-Q · filed 2018-08-07 | -$16.31M derived: sum of 3 quarters · filed 2019-03-13 | |||||
| 2017-03-31 | -$7.45M 10-Q · filed 2018-05-09 | -$13.03M derived: sum of 2 quarters · filed 2019-03-13 | ||||||
| 2016-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$23.69M 10-K · filed 2019-03-13 | ||||||
| 2016-09-30 | -$18.11M 10-Q · filed 2017-11-07 | |||||||
| 2015-12-31 | -$17.57M 10-K · filed 2018-03-14 | |||||||
| 2014-09-30 | -$7.94M 10-Q · filed 2014-11-25 | |||||||
| 2013-09-30 | -$4.91M 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |